Kendall Square CDMO — FDA-Aware Pharmaceutical LinkedIn
Client: Bioanalytical CDMO, Cambridge MA ($14M). Challenge: Pfizer and BMS clinical development teams not seeing clinical expertise. Borderline FDA promotional language in existing posts. Programme: CSO LinkedIn programme + FDA-aware Phase I-III content + CLIA/CAP credential display + Stat News community Results (8 months): Pfizer/BMS clinical development connections: +14 | CLIA content: pharma procurement cited as credibility signal | FDA-aware content: clean throughout | Vendor evaluations from LinkedIn: 5/quarter | Pipeline: $2.8M
